I'll check out the Barron's article. Even with this Medicare decision coming, an alternative to morphine, if effective, should really do well. This current Biotech beat down could just about be over. Seems like they always overdo the sell-offs. (Would like to see some more insider buying.) Good to hear from you.
I agree. Looks too cheap for what they have going. I added some today at $6.08. The company has cash, fast track and Gowen has purchased shares recently. I like it. Not to say we couldn't get cheaper. Entering the summer doldrums, election year and all that.